World Diabetes Foundation (WDF) is an independent trust fund established in 2002 by Novo Nordisk A/S (NN). Based in Copenhagen, Denmark the Foundation is dedicated to supporting prevention and treatment of diabetes in developing countries through funding of sustainable projects. In line with its mission and strategy,  WDF's work encompasses: advocacy, capacity building of both patients and health care professional, prevention, early detection, treatment and monitoring of diabetes. It focuses on the "neglected areas" of diabetes care, which are important not only from a health but socio-economic standpoint, namely prevention of needless foot amputations, blindness as a consequence of diabetes, mothers and diabetes and the recent scientific link between diabetes and tuberculosis. In addition, it creates partnerships and acts as a catalyst to help others do more and strives to educate and advocate globally in an effort to create awareness, care and relief to those impacted by diabetes. To date, close to 300 projects in 100 countries have benefited from WDF support. For more information about WDF and their work, please visit www.worlddiabetesfoundation.org